| 000 | 01091 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514022436.0 | ||
| 264 | 0 | _c20020508 | |
| 008 | 200205s 0 0 eng d | ||
| 022 | _a0305-7453 | ||
| 024 | 7 |
_a10.1093/jac/49.suppl_1.31 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDupont, Bertrand | |
| 245 | 0 | 0 |
_aOverview of the lipid formulations of amphotericin B. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cFeb 2002 |
||
| 300 |
_a31-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAmphotericin B _xadverse effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntifungal Agents _xadverse effects |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLiposomes |
| 650 | 0 | 4 |
_aPhosphatidylcholines _xadverse effects |
| 650 | 0 | 4 |
_aPhosphatidylglycerols _xadverse effects |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 49 Suppl 1 _gp. 31-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/49.suppl_1.31 _zAvailable from publisher's website |
| 999 |
_c11712475 _d11712475 |
||